Page last updated: 2024-12-10

n,n-dimethylpradimicin fa-2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N,N-dimethylpradimicin FA-2: pradimicin A derivative; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3036884
CHEMBL ID1945841
MeSH IDM0185520

Synonyms (10)

Synonym
d-serine, n-((5-((4,6-dideoxy-4-(dimethylamino)-3-o-beta-d-xylopyranosyl-beta-d-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5s-trans)-
d-serine, n-((5-((4,6-dideoxy-4-(dimethylamino)-3-o-beta-d-xylopyranosyl-beta-d-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5s-trans)-, pentahydrate
bmy 28864
131426-59-0
n,n-dimethylpradimicin fa-2
bmy-28864
(2r)-2-[[(5s,6s)-5-[(2s,3r,4s,5s,6r)-5-(dimethylamino)-3-hydroxy-6-methyl-4-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]-3-hydroxypropanoic ac
CHEMBL1945841
DTXSID401098290
n-[[(5s,6s)-5-[[4,6-dideoxy-4-(dimethylamino)-3-o-beta-d-xylopyranosyl-beta-d-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen-2-yl]carbonyl]-d-serine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1717665Antifungal activity against Candida albicans infected in mouse assessed as protection against fungus-induced lethal infection2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID643645Binding affinity to methyl alpha-D-mannopyranoside at -129 ppm by Solid-state CP/MAS 113Cd NMR spectroscopy2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Solid-state NMR analysis of calcium and d-mannose binding of BMY-28864, a water-soluble analogue of pradimicin A.
AID1717664Antifungal activity against Aspergillus fumigatus IAM2034 infected in iv dosed ICR mouse assessed as protection against fungus-induced lethal infection dosed thrice at 48 hrs interval immediately following fungal challenge and measured on day 20 post infe2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID1717704Solubility in water at pH 7.22020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
AID643644Solubility of the compound in phosphate buffered saline at pH 7.42012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Solid-state NMR analysis of calcium and d-mannose binding of BMY-28864, a water-soluble analogue of pradimicin A.
AID643647Binding affinity to [13C6]-methyl alpha-D-mannopyranoside by 2-DDARR in presence of Ca2+ relative to TMS2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Solid-state NMR analysis of calcium and d-mannose binding of BMY-28864, a water-soluble analogue of pradimicin A.
AID1717663Antifungal activity against Candida albicans A9540 infected in iv dosed ICR mouse assessed as protection against fungus-induced lethal infection dosed thrice at 48 hrs interval immediately following fungal challenge and measured on day 20 post infection b2020Journal of medicinal chemistry, 11-12, Volume: 63, Issue:21
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (73.68)18.2507
2000's3 (15.79)29.6817
2010's1 (5.26)24.3611
2020's1 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.60 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (21.05%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (78.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]